107 related articles for article (PubMed ID: 1502829)
1. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with primary lung cancer.
Kim SK; Cho CH; Ahn CM; Jang SH; Lee YH; Kim SK; Chang J; Lee BK; Kim SJ; Youn JK
Yonsei Med J; 1992 Mar; 33(1):41-7. PubMed ID: 1502829
[TBL] [Abstract][Full Text] [Related]
2. Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.
Saijo N; Shimizu E; Irimajiri N; Ozaki A; Kimura K; Takizawa T; Niitani H
J Cancer Res Clin Oncol; 1982; 102(3):195-214. PubMed ID: 7061569
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines.
Kurai J; Chikumi H; Hashimoto K; Yamaguchi K; Yamasaki A; Sako T; Touge H; Makino H; Takata M; Miyata M; Nakamoto M; Burioka N; Shimizu E
Clin Cancer Res; 2007 Mar; 13(5):1552-61. PubMed ID: 17332301
[TBL] [Abstract][Full Text] [Related]
5. Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung.
Saijo N; Shimizu E; Shibuya M; Irimajiri N; Takizawa T; Eguchi K; Shinkai T; Tominaga K; Shimabukuro Z; Taniguchi T; Hoshi A
Br J Cancer; 1982 Aug; 46(2):180-9. PubMed ID: 6185128
[TBL] [Abstract][Full Text] [Related]
6. Impaired zeta chain expression and IFN-gamma production in peripheral blood T and NK cells of patients with advanced lung cancer.
Ciszak L; Kosmaczewska A; Werynska B; Szteblich A; Jankowska R; Frydecka I
Oncol Rep; 2009 Jan; 21(1):173-84. PubMed ID: 19082459
[TBL] [Abstract][Full Text] [Related]
7. [Study of the natural killer cell activity in lung cancer patients].
Lin CC; Kuo YC; Lin CY; Huang WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 May; 20(2):113-8. PubMed ID: 3652779
[TBL] [Abstract][Full Text] [Related]
8. Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome.
Kerndrup G; Meyer K; Ellegaard J; Hokland P
Leuk Res; 1984; 8(2):239-47. PubMed ID: 6717064
[TBL] [Abstract][Full Text] [Related]
9. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
[TBL] [Abstract][Full Text] [Related]
10. Changes in natural killer cell, antibody-dependent cell-mediated cytotoxicity and interferon activities with administration of Nocardia rubra cell wall skeleton to subjects with high risk of lung cancer.
Yamakido M; Ishioka S; Onari K; Matsuzaka S; Yanagida J; Nishimoto Y
Gan; 1983 Dec; 74(6):896-901. PubMed ID: 6199252
[TBL] [Abstract][Full Text] [Related]
11. Impaired antibody-dependent cellular cytotoxicity mediated by herceptin in patients with gastric cancer.
Kono K; Takahashi A; Ichihara F; Sugai H; Fujii H; Matsumoto Y
Cancer Res; 2002 Oct; 62(20):5813-7. PubMed ID: 12384543
[TBL] [Abstract][Full Text] [Related]
12. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
13. Natural killing (NK) and antibody-dependent cellular cytotoxicity (ADCC) in specific pathogen-free (SPF) miniature swine and germfree piglets. III. Two distinct effector cells for NK and ADCC.
Huh ND; Kim YB; Amos DB
J Immunol; 1981 Nov; 127(5):2190-3. PubMed ID: 6457867
[TBL] [Abstract][Full Text] [Related]
14. Natural killer activity and antibody-dependent cell-mediated cytotoxicity in multiple myeloma.
Matsuzaki H; Kagimoto T; Oda T; Kawano F; Takatsuki K
Jpn J Clin Oncol; 1985 Dec; 15(4):611-7. PubMed ID: 4094094
[TBL] [Abstract][Full Text] [Related]
15. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with adult T-cell leukemia.
Uno H; Kawano K; Matsuoka H; Tsuda K
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):730-9. PubMed ID: 2618548
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
17. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
Dato ME; Kim YB
J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell activity and serum autoantibodies in women with postpartum thyroiditis.
Hayslip CC; Baker JR; Wartofsky L; Klein TA; Opsahl MS; Burman KD
J Clin Endocrinol Metab; 1988 May; 66(5):1089-93. PubMed ID: 3360899
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients.
Pircher A; Gamerith G; Amann A; Reinold S; Popper H; Gächter A; Pall G; Wöll E; Jamnig H; Gastl G; Wolf AM; Hilbe W; Wolf D
Lung Cancer; 2014 Jul; 85(1):81-7. PubMed ID: 24780112
[TBL] [Abstract][Full Text] [Related]
20. Natural killer activity and antibody-dependent cell-mediated cytotoxicity in primary glomerular diseases.
Dohi K; Yamada H; Takai M; Fujii Y; Ishikawa H
Clin Nephrol; 1987 Jan; 27(1):11-4. PubMed ID: 3493102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
